vimarsana.com
Home
Live Updates
Pharnext Sca : Pharnext commits to a drastic cost-cutting plan to further enhance the value of its drug candidate for Charcot-Marie-Tooth disease type 1A -January 17, 2024 at 02:35 am EST : vimarsana.com
Pharnext Sca : Pharnext commits to a drastic cost-cutting plan to further enhance the value of its drug candidate for Charcot-Marie-Tooth disease type 1A -January 17, 2024 at 02:35 am EST
PARIS, France, January 17, 2024, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high...
Related Keywords
France ,
Paris ,
France General ,
United States ,
Fabreguettes Leib ,
Anne Charlotte Dudicourt ,
Hugo Brugi ,
Financial Press Relations ,
Euronext Growth Stock Exchange ,
Global Tech Opportunities ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.